0001104659-08-062365 Sample Contracts

COMMON STOCK PURCHASE AGREEMENT
Common Stock Purchase Agreement • October 7th, 2008 • Efficacy Capital, Ltd. • Biological products, (no disgnostic substances) • Texas

This COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of September 29, 2008 by and between Repros Therapeutics Inc., a Delaware corporation, with its principal executive offices located at 2408 Timberloch Place, Suite B-7, The Woodlands, Texas 77380 (the “Company”), and Efficacy Capital, LTD (the “Investor”).

AutoNDA by SimpleDocs
FIRST AMENDMENT TO STANDSTILL AGREEMENT
Standstill Agreement • October 7th, 2008 • Efficacy Capital, Ltd. • Biological products, (no disgnostic substances) • Delaware

This FIRST AMENDMENT TO STANDSTILL AGREEMENT (the “Amendment”), dated as of July , 2008, is by and between REPROS THERAPEUTICS INC., a Delaware corporation (the “Issuer”), and EFFICACY CAPITAL, LTD (“Efficacy”).

Initial Director’s Grant)
Non-Employee Director's Stock Option Agreement • October 7th, 2008 • Efficacy Capital, Ltd. • Biological products, (no disgnostic substances) • Delaware

AGREEMENT made as of the 26th day of September 2008, between REPROS THERAPEUTICS INC., a Delaware corporation (the “Company”), and Mark Lappe (“Director”).

SECOND AMENDMENT TO STANDSTILL AGREEMENT
Standstill Agreement • October 7th, 2008 • Efficacy Capital, Ltd. • Biological products, (no disgnostic substances) • Delaware

This SECOND AMENDMENT TO STANDSTILL AGREEMENT (the “Amendment”), dated as of October 2, 2008, is by and between REPROS THERAPEUTICS INC., a Delaware corporation (the “Issuer”), and EFFICACY CAPITAL, LTD (“Efficacy”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!